Jeanelle Sheeder
Concepts (631)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraception | 19 | 2024 | 170 | 6.470 |
Why?
| | Contraceptive Agents, Female | 26 | 2024 | 80 | 4.170 |
Why?
| | Family Planning Services | 12 | 2023 | 94 | 3.210 |
Why?
| | Contraception Behavior | 19 | 2024 | 108 | 3.110 |
Why?
| | Desogestrel | 22 | 2024 | 46 | 3.050 |
Why?
| | Contraceptive Agents | 7 | 2023 | 65 | 3.040 |
Why?
| | Pregnancy in Adolescence | 18 | 2024 | 84 | 2.920 |
Why?
| | Abortion, Induced | 15 | 2025 | 110 | 2.880 |
Why?
| | Long-Acting Reversible Contraception | 9 | 2024 | 34 | 2.250 |
Why?
| | Pregnancy | 81 | 2025 | 7191 | 2.180 |
Why?
| | Drug Implants | 20 | 2024 | 83 | 1.870 |
Why?
| | Prenatal Care | 9 | 2020 | 307 | 1.800 |
Why?
| | Hospitals, Religious | 5 | 2020 | 5 | 1.580 |
Why?
| | Gynecology | 11 | 2026 | 178 | 1.570 |
Why?
| | Adolescent Health Services | 4 | 2024 | 75 | 1.510 |
Why?
| | Counseling | 6 | 2020 | 408 | 1.440 |
Why?
| | Postpartum Period | 11 | 2024 | 365 | 1.430 |
Why?
| | Intrauterine Devices | 7 | 2019 | 29 | 1.430 |
Why?
| | Health Knowledge, Attitudes, Practice | 12 | 2025 | 1416 | 1.420 |
Why?
| | Adolescent | 91 | 2025 | 22453 | 1.400 |
Why?
| | Female | 174 | 2026 | 78376 | 1.390 |
Why?
| | Young Adult | 68 | 2025 | 14126 | 1.330 |
Why?
| | Obstetrics | 9 | 2026 | 175 | 1.330 |
Why?
| | Adolescent Behavior | 9 | 2015 | 501 | 1.300 |
Why?
| | Pregnancy Outcome | 10 | 2025 | 476 | 1.140 |
Why?
| | Colorado | 36 | 2025 | 4564 | 1.080 |
Why?
| | Reproductive Health | 4 | 2023 | 91 | 1.070 |
Why?
| | Humans | 191 | 2026 | 144957 | 1.060 |
Why?
| | Catholicism | 5 | 2020 | 9 | 1.040 |
Why?
| | Contraception, Postcoital | 2 | 2025 | 9 | 1.040 |
Why?
| | Endometrial Neoplasms | 10 | 2022 | 208 | 1.040 |
Why?
| | Chlamydia Infections | 3 | 2024 | 81 | 1.030 |
Why?
| | Contraceptives, Oral, Combined | 2 | 2023 | 18 | 0.900 |
Why?
| | Postnatal Care | 3 | 2021 | 72 | 0.860 |
Why?
| | Adult | 94 | 2026 | 40506 | 0.840 |
Why?
| | Cross-Sectional Studies | 26 | 2026 | 5872 | 0.840 |
Why?
| | Trichomonas Infections | 1 | 2024 | 11 | 0.820 |
Why?
| | Trichomonas vaginalis | 1 | 2024 | 11 | 0.820 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 886 | 0.810 |
Why?
| | Confidentiality | 1 | 2024 | 79 | 0.800 |
Why?
| | Patient Satisfaction | 6 | 2025 | 705 | 0.790 |
Why?
| | Surveys and Questionnaires | 27 | 2026 | 6053 | 0.790 |
Why?
| | Sexual Behavior | 7 | 2022 | 492 | 0.780 |
Why?
| | Enoxaparin | 2 | 2020 | 67 | 0.760 |
Why?
| | Religion and Medicine | 3 | 2020 | 33 | 0.720 |
Why?
| | Pyridones | 2 | 2020 | 199 | 0.710 |
Why?
| | Sexually Transmitted Diseases | 1 | 2024 | 166 | 0.700 |
Why?
| | Levonorgestrel | 4 | 2018 | 35 | 0.650 |
Why?
| | Parity | 5 | 2016 | 109 | 0.630 |
Why?
| | Ambulatory Care Facilities | 5 | 2024 | 266 | 0.630 |
Why?
| | Group Processes | 2 | 2018 | 64 | 0.620 |
Why?
| | Mothers | 5 | 2022 | 775 | 0.610 |
Why?
| | Religion and Psychology | 1 | 2019 | 27 | 0.610 |
Why?
| | Pyrazoles | 2 | 2020 | 510 | 0.600 |
Why?
| | Hysterectomy | 6 | 2019 | 138 | 0.600 |
Why?
| | Health Services Accessibility | 5 | 2026 | 1099 | 0.600 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 104 | 0.590 |
Why?
| | Venous Thromboembolism | 2 | 2020 | 324 | 0.590 |
Why?
| | Pregnancy Rate | 2 | 2017 | 69 | 0.580 |
Why?
| | Patient-Centered Care | 2 | 2021 | 544 | 0.580 |
Why?
| | Intention | 5 | 2024 | 183 | 0.580 |
Why?
| | Sex Offenses | 1 | 2022 | 196 | 0.580 |
Why?
| | Community Health Services | 2 | 2023 | 234 | 0.570 |
Why?
| | Financial Support | 1 | 2018 | 17 | 0.560 |
Why?
| | Vulnerable Populations | 1 | 2020 | 177 | 0.560 |
Why?
| | Health Care Sector | 1 | 2018 | 26 | 0.560 |
Why?
| | Intrauterine Devices, Copper | 5 | 2018 | 7 | 0.550 |
Why?
| | Rural Health Services | 1 | 2019 | 141 | 0.550 |
Why?
| | Ovarian Neoplasms | 6 | 2020 | 586 | 0.540 |
Why?
| | Pregnancy, Unplanned | 3 | 2017 | 48 | 0.540 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 292 | 0.530 |
Why?
| | Prosthesis Implantation | 2 | 2017 | 153 | 0.530 |
Why?
| | Premature Birth | 2 | 2025 | 380 | 0.510 |
Why?
| | Retrospective Studies | 36 | 2025 | 17101 | 0.500 |
Why?
| | Luteal Phase | 1 | 2017 | 46 | 0.500 |
Why?
| | Intrauterine Devices, Medicated | 6 | 2017 | 27 | 0.500 |
Why?
| | Chlamydia trachomatis | 3 | 2024 | 49 | 0.490 |
Why?
| | Infant, Low Birth Weight | 2 | 2015 | 153 | 0.490 |
Why?
| | Delivery of Health Care | 2 | 2023 | 947 | 0.490 |
Why?
| | Lacerations | 3 | 2022 | 40 | 0.470 |
Why?
| | Parenting | 1 | 2020 | 318 | 0.460 |
Why?
| | Interprofessional Relations | 1 | 2018 | 281 | 0.460 |
Why?
| | Life Style | 4 | 2024 | 479 | 0.460 |
Why?
| | Depression, Postpartum | 3 | 2020 | 128 | 0.460 |
Why?
| | Group Structure | 1 | 2015 | 2 | 0.450 |
Why?
| | Risk | 2 | 2017 | 911 | 0.440 |
Why?
| | Guatemala | 3 | 2021 | 345 | 0.440 |
Why?
| | Perimenopause | 1 | 2015 | 66 | 0.440 |
Why?
| | Carcinoma, Endometrioid | 3 | 2022 | 51 | 0.440 |
Why?
| | Genital Neoplasms, Female | 4 | 2020 | 99 | 0.440 |
Why?
| | Fertility Preservation | 3 | 2023 | 53 | 0.430 |
Why?
| | Health Personnel | 1 | 2021 | 748 | 0.420 |
Why?
| | Uterus | 1 | 2015 | 226 | 0.420 |
Why?
| | Patient Selection | 3 | 2015 | 719 | 0.410 |
Why?
| | Safety-net Providers | 1 | 2015 | 126 | 0.410 |
Why?
| | Multicenter Studies as Topic | 1 | 2015 | 405 | 0.410 |
Why?
| | Maternal Age | 3 | 2018 | 126 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2019 | 1721 | 0.400 |
Why?
| | Attitude to Health | 3 | 2020 | 436 | 0.380 |
Why?
| | Quality Improvement | 5 | 2025 | 1291 | 0.370 |
Why?
| | Primary Health Care | 4 | 2023 | 1734 | 0.370 |
Why?
| | Goals | 1 | 2014 | 184 | 0.370 |
Why?
| | Choice Behavior | 3 | 2019 | 178 | 0.360 |
Why?
| | Estradiol | 1 | 2015 | 533 | 0.360 |
Why?
| | Middle Aged | 40 | 2026 | 35928 | 0.350 |
Why?
| | Uterine Cervical Neoplasms | 3 | 2021 | 269 | 0.350 |
Why?
| | Mass Screening | 9 | 2023 | 1348 | 0.350 |
Why?
| | Papillomavirus Vaccines | 1 | 2015 | 297 | 0.350 |
Why?
| | Internship and Residency | 6 | 2023 | 1257 | 0.340 |
Why?
| | Delivery, Obstetric | 5 | 2025 | 160 | 0.340 |
Why?
| | Gestational Age | 5 | 2024 | 975 | 0.340 |
Why?
| | Progesterone | 2 | 2025 | 255 | 0.330 |
Why?
| | Obstetric Labor Complications | 2 | 2022 | 38 | 0.330 |
Why?
| | Child | 19 | 2024 | 22657 | 0.330 |
Why?
| | Disclosure | 2 | 2022 | 85 | 0.320 |
Why?
| | Postoperative Complications | 9 | 2020 | 2920 | 0.320 |
Why?
| | Magnetoencephalography | 13 | 2000 | 162 | 0.310 |
Why?
| | United States | 20 | 2025 | 15988 | 0.310 |
Why?
| | Functional Laterality | 11 | 2001 | 241 | 0.300 |
Why?
| | Health Behavior | 1 | 2015 | 786 | 0.300 |
Why?
| | Socioeconomic Factors | 5 | 2021 | 1327 | 0.300 |
Why?
| | Lymph Nodes | 3 | 2018 | 502 | 0.300 |
Why?
| | Nurse Midwives | 2 | 2020 | 43 | 0.300 |
Why?
| | Feasibility Studies | 7 | 2022 | 1095 | 0.300 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1186 | 0.300 |
Why?
| | Condoms | 3 | 2017 | 101 | 0.290 |
Why?
| | Evoked Potentials, Auditory | 10 | 2001 | 180 | 0.290 |
Why?
| | Birth Intervals | 2 | 2019 | 23 | 0.290 |
Why?
| | Robotic Surgical Procedures | 3 | 2016 | 182 | 0.280 |
Why?
| | Communication | 3 | 2022 | 967 | 0.280 |
Why?
| | Intrauterine Device Expulsion | 3 | 2017 | 9 | 0.280 |
Why?
| | Male | 46 | 2024 | 72406 | 0.270 |
Why?
| | Patient Participation | 1 | 2012 | 433 | 0.270 |
Why?
| | Infant, Small for Gestational Age | 2 | 2019 | 109 | 0.270 |
Why?
| | Women's Health | 2 | 2020 | 310 | 0.270 |
Why?
| | Time Factors | 12 | 2024 | 7183 | 0.260 |
Why?
| | Sexual Partners | 3 | 2024 | 192 | 0.260 |
Why?
| | Attitude | 3 | 2019 | 261 | 0.260 |
Why?
| | Prediabetic State | 2 | 2023 | 245 | 0.260 |
Why?
| | Cohort Studies | 11 | 2021 | 5965 | 0.250 |
Why?
| | Uterine Cervicitis | 1 | 2006 | 7 | 0.250 |
Why?
| | Vaccination | 1 | 2015 | 1423 | 0.250 |
Why?
| | Organizational Policy | 2 | 2019 | 76 | 0.240 |
Why?
| | Pregnancy Complications | 4 | 2019 | 592 | 0.240 |
Why?
| | Healthcare Disparities | 2 | 2025 | 728 | 0.240 |
Why?
| | Age Factors | 8 | 2016 | 3335 | 0.230 |
Why?
| | Perineum | 3 | 2022 | 37 | 0.230 |
Why?
| | Analgesia, Obstetrical | 1 | 2025 | 32 | 0.230 |
Why?
| | Marijuana Use | 2 | 2019 | 213 | 0.230 |
Why?
| | Cerclage, Cervical | 1 | 2025 | 9 | 0.220 |
Why?
| | Cesarean Section | 2 | 2025 | 224 | 0.220 |
Why?
| | Pregnancy Trimester, First | 4 | 2023 | 136 | 0.220 |
Why?
| | Prospective Studies | 14 | 2022 | 7997 | 0.220 |
Why?
| | Gelatin | 2 | 2016 | 56 | 0.220 |
Why?
| | Electronics, Medical | 1 | 2004 | 7 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2584 | 0.220 |
Why?
| | Fetal Death | 2 | 2016 | 58 | 0.220 |
Why?
| | Laparotomy | 2 | 2015 | 112 | 0.220 |
Why?
| | Perinatal Care | 1 | 2025 | 62 | 0.220 |
Why?
| | Labor, Induced | 1 | 2025 | 39 | 0.220 |
Why?
| | Aged, 80 and over | 11 | 2021 | 8279 | 0.210 |
Why?
| | Progestins | 1 | 2025 | 87 | 0.210 |
Why?
| | Database Management Systems | 1 | 2004 | 50 | 0.210 |
Why?
| | Legal Guardians | 1 | 2024 | 10 | 0.210 |
Why?
| | Weight Gain | 6 | 2021 | 559 | 0.210 |
Why?
| | Thrombin | 2 | 2016 | 166 | 0.210 |
Why?
| | Midwifery | 1 | 2025 | 64 | 0.210 |
Why?
| | Depression | 4 | 2023 | 1559 | 0.210 |
Why?
| | Contact Tracing | 1 | 2024 | 26 | 0.210 |
Why?
| | Aged | 18 | 2021 | 25947 | 0.210 |
Why?
| | Privacy | 1 | 2024 | 41 | 0.200 |
Why?
| | Analgesics, Opioid | 2 | 2025 | 1143 | 0.200 |
Why?
| | Aromatherapy | 1 | 2023 | 2 | 0.200 |
Why?
| | Clinical Competence | 3 | 2018 | 1244 | 0.200 |
Why?
| | Pregnancy Trimester, Second | 4 | 2018 | 82 | 0.200 |
Why?
| | Scapula | 1 | 2024 | 48 | 0.200 |
Why?
| | Contraceptive Devices | 1 | 2023 | 3 | 0.200 |
Why?
| | Ethinyl Estradiol | 1 | 2023 | 16 | 0.200 |
Why?
| | Pediatricians | 1 | 2024 | 121 | 0.200 |
Why?
| | Birth Weight | 1 | 2006 | 522 | 0.200 |
Why?
| | Cost-Benefit Analysis | 3 | 2020 | 636 | 0.200 |
Why?
| | Telemedicine | 2 | 2023 | 948 | 0.190 |
Why?
| | Social Support | 2 | 2020 | 652 | 0.190 |
Why?
| | Patient Health Questionnaire | 1 | 2023 | 41 | 0.190 |
Why?
| | Physician's Role | 1 | 2024 | 220 | 0.190 |
Why?
| | Device Removal | 1 | 2024 | 143 | 0.190 |
Why?
| | Fertility | 3 | 2023 | 168 | 0.190 |
Why?
| | Pain | 2 | 2018 | 782 | 0.190 |
Why?
| | Fellowships and Scholarships | 2 | 2018 | 357 | 0.190 |
Why?
| | Leuprolide | 1 | 2022 | 21 | 0.190 |
Why?
| | Pediatrics | 2 | 2024 | 1115 | 0.190 |
Why?
| | Decision Making | 4 | 2016 | 980 | 0.190 |
Why?
| | House Calls | 2 | 2019 | 154 | 0.190 |
Why?
| | Semen | 1 | 2022 | 23 | 0.190 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 115 | 0.190 |
Why?
| | Pregnancy Tests | 2 | 2017 | 10 | 0.180 |
Why?
| | Patient Preference | 2 | 2015 | 225 | 0.180 |
Why?
| | Exercise | 3 | 2024 | 2201 | 0.170 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 27 | 0.170 |
Why?
| | Infant, Newborn | 8 | 2025 | 6434 | 0.170 |
Why?
| | Chorioamnionitis | 1 | 2021 | 45 | 0.170 |
Why?
| | Students, Medical | 2 | 2016 | 375 | 0.170 |
Why?
| | beta Catenin | 2 | 2022 | 253 | 0.160 |
Why?
| | Maternal-Child Health Services | 1 | 2020 | 12 | 0.160 |
Why?
| | Decision Support Techniques | 2 | 2020 | 456 | 0.160 |
Why?
| | Pilot Projects | 4 | 2024 | 1890 | 0.160 |
Why?
| | Lymph Node Excision | 3 | 2018 | 173 | 0.160 |
Why?
| | Parturition | 2 | 2019 | 69 | 0.160 |
Why?
| | Self Report | 3 | 2021 | 873 | 0.160 |
Why?
| | Evoked Potentials, Somatosensory | 2 | 1999 | 39 | 0.160 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 121 | 0.160 |
Why?
| | Magnetics | 2 | 1999 | 48 | 0.160 |
Why?
| | Accelerometry | 1 | 2021 | 119 | 0.160 |
Why?
| | Patient Education as Topic | 3 | 2019 | 780 | 0.150 |
Why?
| | Home Health Nursing | 1 | 2019 | 13 | 0.150 |
Why?
| | Uterine Hemorrhage | 2 | 2021 | 41 | 0.150 |
Why?
| | Menstruation Disturbances | 1 | 2019 | 13 | 0.150 |
Why?
| | Health Facilities | 1 | 2020 | 85 | 0.150 |
Why?
| | Pharmacogenetics | 1 | 2021 | 173 | 0.150 |
Why?
| | Outpatients | 3 | 2023 | 443 | 0.150 |
Why?
| | Factor Analysis, Statistical | 1 | 2020 | 293 | 0.150 |
Why?
| | Hysterectomy, Vaginal | 1 | 2019 | 6 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2023 | 576 | 0.150 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2019 | 4 | 0.150 |
Why?
| | Cytochrome P450 Family 3 | 1 | 2019 | 3 | 0.150 |
Why?
| | Body Mass Index | 5 | 2024 | 2438 | 0.150 |
Why?
| | Vaginosis, Bacterial | 1 | 2019 | 10 | 0.150 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 80 | 0.150 |
Why?
| | Cues | 1 | 2022 | 326 | 0.150 |
Why?
| | Transgender Persons | 1 | 2022 | 191 | 0.150 |
Why?
| | Insulin Resistance | 2 | 2008 | 1241 | 0.150 |
Why?
| | Clothing | 1 | 2019 | 23 | 0.150 |
Why?
| | Hygiene | 1 | 2019 | 29 | 0.150 |
Why?
| | Neoplasm Staging | 6 | 2020 | 1465 | 0.150 |
Why?
| | Double-Blind Method | 5 | 2018 | 2029 | 0.140 |
Why?
| | Live Birth | 1 | 2019 | 68 | 0.140 |
Why?
| | Cancer Pain | 1 | 2019 | 36 | 0.140 |
Why?
| | Anesthesia, Inhalation | 1 | 2018 | 14 | 0.140 |
Why?
| | Anesthesia, Intravenous | 1 | 2018 | 24 | 0.140 |
Why?
| | Obesity | 5 | 2016 | 3082 | 0.140 |
Why?
| | Medical Oncology | 2 | 2019 | 332 | 0.140 |
Why?
| | Nitrous Oxide | 1 | 2018 | 35 | 0.140 |
Why?
| | Models, Anatomic | 1 | 2019 | 84 | 0.140 |
Why?
| | Anesthetics, Intravenous | 1 | 2018 | 69 | 0.140 |
Why?
| | Genitalia, Female | 1 | 2018 | 42 | 0.140 |
Why?
| | Physician Assistants | 1 | 2020 | 102 | 0.140 |
Why?
| | Databases as Topic | 2 | 2008 | 71 | 0.140 |
Why?
| | Databases, Factual | 3 | 2021 | 1486 | 0.140 |
Why?
| | Anesthetics, Inhalation | 1 | 2018 | 52 | 0.140 |
Why?
| | Hemostasis, Surgical | 2 | 2016 | 27 | 0.140 |
Why?
| | Treatment Outcome | 10 | 2020 | 11695 | 0.140 |
Why?
| | Organ Transplantation | 1 | 2021 | 248 | 0.140 |
Why?
| | Ovariectomy | 2 | 2015 | 162 | 0.140 |
Why?
| | Off-Label Use | 1 | 2018 | 51 | 0.140 |
Why?
| | Culture | 1 | 2019 | 125 | 0.130 |
Why?
| | Risk-Taking | 2 | 2019 | 328 | 0.130 |
Why?
| | Conflict of Interest | 1 | 2018 | 53 | 0.130 |
Why?
| | Nurse Practitioners | 1 | 2020 | 140 | 0.130 |
Why?
| | Logistic Models | 6 | 2024 | 2119 | 0.130 |
Why?
| | Oncologists | 1 | 2018 | 46 | 0.130 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 103 | 0.130 |
Why?
| | Psychometrics | 4 | 2009 | 734 | 0.130 |
Why?
| | Adenocarcinoma | 2 | 2015 | 931 | 0.130 |
Why?
| | Commerce | 1 | 2018 | 79 | 0.130 |
Why?
| | Sterilization, Reproductive | 1 | 2017 | 8 | 0.130 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 84 | 0.130 |
Why?
| | Hysteroscopy | 1 | 2017 | 13 | 0.130 |
Why?
| | Quality of Health Care | 2 | 2021 | 693 | 0.130 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2018 | 76 | 0.130 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.130 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1958 | 0.130 |
Why?
| | Salpingectomy | 2 | 2015 | 15 | 0.130 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2017 | 30 | 0.130 |
Why?
| | Professional-Patient Relations | 1 | 2018 | 154 | 0.120 |
Why?
| | Abortion, Therapeutic | 1 | 2016 | 3 | 0.120 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 203 | 0.120 |
Why?
| | Brain Diseases | 1 | 1998 | 153 | 0.120 |
Why?
| | Dilatation and Curettage | 1 | 2016 | 12 | 0.120 |
Why?
| | Incidence | 5 | 2019 | 2883 | 0.120 |
Why?
| | Ultrasonography | 2 | 2019 | 770 | 0.120 |
Why?
| | Pelvic Infection | 1 | 2016 | 6 | 0.120 |
Why?
| | Family | 1 | 2021 | 679 | 0.120 |
Why?
| | Surgeons | 2 | 2018 | 340 | 0.120 |
Why?
| | Bipolar Disorder | 1 | 1999 | 280 | 0.120 |
Why?
| | Minority Groups | 1 | 2018 | 282 | 0.120 |
Why?
| | Medical Marijuana | 1 | 2018 | 123 | 0.120 |
Why?
| | Tissue Adhesives | 1 | 2016 | 22 | 0.120 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2017 | 74 | 0.120 |
Why?
| | Follow-Up Studies | 8 | 2019 | 5417 | 0.120 |
Why?
| | Surgical Wound Infection | 1 | 2019 | 316 | 0.120 |
Why?
| | Cerebral Cortex | 1 | 1999 | 465 | 0.120 |
Why?
| | Pregnancy, Unwanted | 1 | 2015 | 15 | 0.120 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2015 | 37 | 0.120 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 137 | 0.120 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 125 | 0.110 |
Why?
| | Infant | 3 | 2023 | 10039 | 0.110 |
Why?
| | Internet | 2 | 2019 | 700 | 0.110 |
Why?
| | Placebos | 1 | 2015 | 193 | 0.110 |
Why?
| | Patient Compliance | 2 | 2012 | 589 | 0.110 |
Why?
| | Risk Reduction Behavior | 2 | 2014 | 226 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 603 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 7 | 2001 | 3869 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 631 | 0.110 |
Why?
| | Interpersonal Relations | 2 | 2017 | 400 | 0.110 |
Why?
| | Contraceptives, Oral | 1 | 2015 | 37 | 0.110 |
Why?
| | Hot Flashes | 1 | 2015 | 88 | 0.110 |
Why?
| | Anticoagulants | 1 | 2020 | 724 | 0.110 |
Why?
| | Papillomaviridae | 1 | 2015 | 115 | 0.110 |
Why?
| | Radiography, Thoracic | 1 | 2016 | 171 | 0.110 |
Why?
| | Physician-Patient Relations | 2 | 2019 | 588 | 0.110 |
Why?
| | Abdominal Abscess | 1 | 2014 | 25 | 0.110 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 183 | 0.110 |
Why?
| | Curriculum | 3 | 2018 | 1060 | 0.110 |
Why?
| | Advanced Practice Nursing | 1 | 2015 | 45 | 0.110 |
Why?
| | Pandemics | 1 | 2023 | 1695 | 0.110 |
Why?
| | Risk Factors | 10 | 2022 | 10792 | 0.110 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2015 | 194 | 0.110 |
Why?
| | Immunization Schedule | 1 | 2015 | 187 | 0.100 |
Why?
| | Schizophrenia | 4 | 2000 | 446 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 984 | 0.100 |
Why?
| | Endometrium | 1 | 2014 | 61 | 0.100 |
Why?
| | Glycoproteins | 1 | 2015 | 355 | 0.100 |
Why?
| | Neoplasm Grading | 3 | 2022 | 309 | 0.100 |
Why?
| | Digoxin | 1 | 2013 | 27 | 0.100 |
Why?
| | Fatigue | 1 | 2015 | 366 | 0.100 |
Why?
| | Robotics | 1 | 2014 | 87 | 0.100 |
Why?
| | Otolaryngology | 1 | 2015 | 108 | 0.100 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2013 | 19 | 0.100 |
Why?
| | Pelvic Neoplasms | 1 | 2013 | 24 | 0.100 |
Why?
| | Umbilical Cord | 1 | 2013 | 91 | 0.100 |
Why?
| | Motivational Interviewing | 1 | 2014 | 121 | 0.090 |
Why?
| | Brain | 8 | 2001 | 2941 | 0.090 |
Why?
| | Antigens, CD | 1 | 2015 | 555 | 0.090 |
Why?
| | Travel | 2 | 2024 | 136 | 0.090 |
Why?
| | Peer Group | 1 | 2015 | 257 | 0.090 |
Why?
| | Overweight | 1 | 2017 | 609 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1141 | 0.090 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2013 | 84 | 0.090 |
Why?
| | Drug Monitoring | 1 | 2015 | 395 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2015 | 412 | 0.090 |
Why?
| | School Health Services | 1 | 2014 | 224 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1358 | 0.090 |
Why?
| | Guideline Adherence | 2 | 2021 | 589 | 0.080 |
Why?
| | Abortion Applicants | 1 | 2010 | 3 | 0.080 |
Why?
| | Glucose Tolerance Test | 2 | 2013 | 361 | 0.080 |
Why?
| | Papillomavirus Infections | 1 | 2015 | 345 | 0.080 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 601 | 0.080 |
Why?
| | Hemorrhage | 1 | 2016 | 809 | 0.080 |
Why?
| | Odds Ratio | 2 | 2016 | 1077 | 0.080 |
Why?
| | Rural Population | 3 | 2022 | 650 | 0.080 |
Why?
| | Domestic Violence | 1 | 2010 | 51 | 0.080 |
Why?
| | Anal Canal | 2 | 2022 | 102 | 0.080 |
Why?
| | Health Care Costs | 1 | 2014 | 427 | 0.080 |
Why?
| | Blood Loss, Surgical | 3 | 2016 | 112 | 0.080 |
Why?
| | Education, Medical, Graduate | 1 | 2015 | 557 | 0.080 |
Why?
| | Clinical Clerkship | 1 | 2011 | 111 | 0.080 |
Why?
| | Pain Measurement | 2 | 2025 | 555 | 0.080 |
Why?
| | Pediatric Obesity | 1 | 2017 | 638 | 0.080 |
Why?
| | Peptides | 1 | 2015 | 998 | 0.080 |
Why?
| | Neoplasm Invasiveness | 3 | 2017 | 509 | 0.080 |
Why?
| | Linear Models | 3 | 2019 | 854 | 0.080 |
Why?
| | Misoprostol | 1 | 2009 | 15 | 0.070 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2009 | 19 | 0.070 |
Why?
| | Latin America | 1 | 2009 | 94 | 0.070 |
Why?
| | Risk Assessment | 4 | 2016 | 3676 | 0.070 |
Why?
| | Preoperative Care | 3 | 2017 | 380 | 0.070 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2020 | 64 | 0.070 |
Why?
| | Research Design | 1 | 2015 | 1137 | 0.070 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2009 | 95 | 0.070 |
Why?
| | Interferon-beta | 2 | 2000 | 92 | 0.070 |
Why?
| | Dominance, Cerebral | 2 | 2000 | 56 | 0.070 |
Why?
| | Case-Control Studies | 5 | 2020 | 3608 | 0.070 |
Why?
| | Referral and Consultation | 2 | 2018 | 853 | 0.070 |
Why?
| | Sleep | 1 | 2015 | 901 | 0.070 |
Why?
| | Menarche | 1 | 2008 | 52 | 0.070 |
Why?
| | Smoking | 1 | 2015 | 1472 | 0.070 |
Why?
| | Nausea | 2 | 2019 | 111 | 0.070 |
Why?
| | Models, Theoretical | 1 | 2012 | 582 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2025 | 1540 | 0.070 |
Why?
| | Temporal Lobe | 3 | 1997 | 104 | 0.070 |
Why?
| | Sex Factors | 6 | 2020 | 2114 | 0.070 |
Why?
| | Weight Loss | 2 | 2017 | 837 | 0.070 |
Why?
| | Schizophrenia, Paranoid | 2 | 1997 | 9 | 0.070 |
Why?
| | Breast Feeding | 1 | 2012 | 448 | 0.070 |
Why?
| | Psychotic Disorders | 2 | 2000 | 186 | 0.070 |
Why?
| | Comorbidity | 2 | 2016 | 1660 | 0.060 |
Why?
| | Reference Values | 3 | 2018 | 798 | 0.060 |
Why?
| | Societies, Medical | 3 | 2018 | 887 | 0.060 |
Why?
| | Students, Health Occupations | 1 | 2007 | 37 | 0.060 |
Why?
| | Healthy Volunteers | 2 | 2019 | 215 | 0.060 |
Why?
| | Fathers | 1 | 2006 | 51 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2022 | 531 | 0.060 |
Why?
| | Clinical Laboratory Techniques | 1 | 2007 | 96 | 0.060 |
Why?
| | False Positive Reactions | 1 | 2006 | 122 | 0.060 |
Why?
| | Science | 1 | 2007 | 56 | 0.060 |
Why?
| | Auditory Cortex | 2 | 1997 | 47 | 0.060 |
Why?
| | Prognosis | 4 | 2018 | 4293 | 0.060 |
Why?
| | Urethritis | 1 | 2005 | 4 | 0.060 |
Why?
| | Uterine Cervical Diseases | 1 | 2005 | 6 | 0.060 |
Why?
| | Azithromycin | 1 | 2006 | 104 | 0.060 |
Why?
| | Maternal Health Services | 1 | 2007 | 102 | 0.060 |
Why?
| | Prevalence | 2 | 2017 | 2836 | 0.060 |
Why?
| | Self Efficacy | 2 | 2019 | 414 | 0.060 |
Why?
| | Fatty Liver | 1 | 2008 | 251 | 0.060 |
Why?
| | Length of Stay | 3 | 2015 | 1337 | 0.060 |
Why?
| | Dilatation | 1 | 2025 | 72 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 1998 | 2456 | 0.050 |
Why?
| | Teaching | 1 | 2007 | 236 | 0.050 |
Why?
| | Chronic Disease | 2 | 2024 | 1813 | 0.050 |
Why?
| | Metformin | 1 | 2008 | 319 | 0.050 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 354 | 0.050 |
Why?
| | Herb-Drug Interactions | 1 | 2023 | 4 | 0.050 |
Why?
| | Acanthosis Nigricans | 1 | 2003 | 4 | 0.050 |
Why?
| | Hospitals, University | 2 | 2016 | 176 | 0.050 |
Why?
| | Texas | 1 | 2024 | 278 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1268 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2008 | 1495 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A Inducers | 1 | 2023 | 5 | 0.050 |
Why?
| | Biomarkers, Tumor | 2 | 2022 | 1322 | 0.050 |
Why?
| | Ovulation | 1 | 2023 | 41 | 0.050 |
Why?
| | Urban Population | 2 | 2016 | 491 | 0.050 |
Why?
| | Program Evaluation | 2 | 2019 | 949 | 0.050 |
Why?
| | Rifampin | 1 | 2023 | 82 | 0.050 |
Why?
| | Diet | 2 | 2024 | 1275 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2642 | 0.050 |
Why?
| | Episiotomy | 1 | 2022 | 5 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2017 | 2947 | 0.040 |
Why?
| | Pregnancy, Twin | 1 | 2021 | 19 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2022 | 140 | 0.040 |
Why?
| | Pain Management | 1 | 2025 | 405 | 0.040 |
Why?
| | Anxiety | 2 | 2019 | 1110 | 0.040 |
Why?
| | Pharmacogenomic Variants | 1 | 2021 | 33 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2884 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2014 | 1915 | 0.040 |
Why?
| | Reproduction | 1 | 2022 | 207 | 0.040 |
Why?
| | Alpha Rhythm | 1 | 2000 | 11 | 0.040 |
Why?
| | Analysis of Variance | 5 | 2005 | 1311 | 0.040 |
Why?
| | Biomedical Research | 1 | 2007 | 710 | 0.040 |
Why?
| | Time-to-Pregnancy | 1 | 2020 | 3 | 0.040 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 2020 | 52 | 0.040 |
Why?
| | Wrist | 1 | 2021 | 60 | 0.040 |
Why?
| | Coitus | 2 | 2011 | 23 | 0.040 |
Why?
| | Mother-Child Relations | 1 | 2021 | 134 | 0.040 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2019 | 19 | 0.040 |
Why?
| | Refractory Period, Electrophysiological | 1 | 1999 | 5 | 0.040 |
Why?
| | Ethics, Medical | 1 | 2020 | 90 | 0.040 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2019 | 26 | 0.040 |
Why?
| | Poverty | 2 | 2017 | 530 | 0.040 |
Why?
| | Median Nerve | 1 | 1999 | 27 | 0.040 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 67 | 0.040 |
Why?
| | Ethics, Institutional | 1 | 2019 | 4 | 0.040 |
Why?
| | Needs Assessment | 2 | 2015 | 404 | 0.040 |
Why?
| | Visible Human Projects | 1 | 2019 | 2 | 0.040 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 82 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2019 | 31 | 0.040 |
Why?
| | Mutation | 2 | 2022 | 4099 | 0.040 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3415 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2000 | 178 | 0.040 |
Why?
| | DNA Polymerase II | 1 | 2019 | 35 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 36 | 0.040 |
Why?
| | Reproductive Health Services | 1 | 2019 | 18 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 424 | 0.040 |
Why?
| | Microsatellite Instability | 1 | 2019 | 54 | 0.040 |
Why?
| | Pituitary Gland | 1 | 1999 | 148 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2000 | 245 | 0.040 |
Why?
| | Electroencephalography | 2 | 1999 | 551 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 20 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2018 | 80 | 0.040 |
Why?
| | Operative Time | 1 | 2019 | 175 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 419 | 0.040 |
Why?
| | Morning Sickness | 1 | 2018 | 3 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 109 | 0.030 |
Why?
| | Electric Stimulation | 1 | 1999 | 276 | 0.030 |
Why?
| | Midazolam | 1 | 2018 | 72 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1389 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1990 | 0.030 |
Why?
| | Psychology, Adolescent | 2 | 2008 | 63 | 0.030 |
Why?
| | Carmustine | 1 | 1998 | 52 | 0.030 |
Why?
| | Frozen Sections | 1 | 2018 | 24 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1500 | 0.030 |
Why?
| | Memory, Short-Term | 1 | 2000 | 271 | 0.030 |
Why?
| | Memory | 2 | 1999 | 296 | 0.030 |
Why?
| | Patient Care | 1 | 2019 | 118 | 0.030 |
Why?
| | Thalamus | 1 | 1999 | 126 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1998 | 88 | 0.030 |
Why?
| | PTEN Phosphohydrolase | 1 | 2019 | 165 | 0.030 |
Why?
| | Creatine | 1 | 1998 | 63 | 0.030 |
Why?
| | Legislation, Drug | 1 | 2018 | 73 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2019 | 769 | 0.030 |
Why?
| | Hysterosalpingography | 1 | 2017 | 8 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2019 | 239 | 0.030 |
Why?
| | Cyclophosphamide | 1 | 1998 | 266 | 0.030 |
Why?
| | Fentanyl | 1 | 2018 | 127 | 0.030 |
Why?
| | Sterilization, Tubal | 1 | 2017 | 17 | 0.030 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2197 | 0.030 |
Why?
| | Transcription Factors | 1 | 2005 | 1742 | 0.030 |
Why?
| | Hippocampus | 2 | 2001 | 967 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 518 | 0.030 |
Why?
| | Survival Analysis | 1 | 2020 | 1385 | 0.030 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 463 | 0.030 |
Why?
| | Hospitals, Private | 1 | 2016 | 12 | 0.030 |
Why?
| | Health Facility Size | 1 | 2016 | 13 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 1998 | 421 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 2092 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 122 | 0.030 |
Why?
| | AC133 Antigen | 1 | 2015 | 20 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2019 | 211 | 0.030 |
Why?
| | Self Care | 1 | 2019 | 389 | 0.030 |
Why?
| | Cisplatin | 1 | 1998 | 334 | 0.030 |
Why?
| | Medical Audit | 1 | 2016 | 77 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2016 | 119 | 0.030 |
Why?
| | Marriage | 1 | 2017 | 122 | 0.030 |
Why?
| | Radiotherapy | 1 | 2016 | 206 | 0.030 |
Why?
| | Brain Injuries | 1 | 2001 | 508 | 0.030 |
Why?
| | Patient Simulation | 1 | 2015 | 41 | 0.030 |
Why?
| | Reaction Time | 4 | 2000 | 438 | 0.030 |
Why?
| | Stem Cell Transplantation | 1 | 2016 | 191 | 0.030 |
Why?
| | North America | 1 | 2016 | 310 | 0.030 |
Why?
| | Indians, North American | 1 | 2021 | 647 | 0.030 |
Why?
| | Ileus | 1 | 2015 | 13 | 0.030 |
Why?
| | Cell Count | 1 | 2015 | 321 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2006 | 529 | 0.030 |
Why?
| | Income | 1 | 2016 | 202 | 0.030 |
Why?
| | Urinary Retention | 1 | 2015 | 25 | 0.030 |
Why?
| | Terminal Care | 1 | 2019 | 282 | 0.030 |
Why?
| | Competitive Behavior | 1 | 2015 | 43 | 0.030 |
Why?
| | Female Urogenital Diseases | 1 | 2014 | 7 | 0.030 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 29 | 0.030 |
Why?
| | Natural Family Planning Methods | 1 | 2014 | 2 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 323 | 0.030 |
Why?
| | Receptors, Androgen | 1 | 2015 | 153 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 201 | 0.030 |
Why?
| | Peritoneal Cavity | 1 | 2014 | 30 | 0.030 |
Why?
| | Laparoscopy | 1 | 2019 | 475 | 0.030 |
Why?
| | Memory Disorders | 1 | 1996 | 194 | 0.030 |
Why?
| | Blood Volume | 1 | 2014 | 65 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 2015 | 156 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2925 | 0.030 |
Why?
| | Homosexuality, Male | 1 | 1995 | 222 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 299 | 0.030 |
Why?
| | Acoustic Stimulation | 3 | 2000 | 334 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 201 | 0.030 |
Why?
| | Hemostatics | 1 | 2014 | 61 | 0.030 |
Why?
| | Pelvis | 1 | 2015 | 124 | 0.030 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 271 | 0.030 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 18 | 0.030 |
Why?
| | Receptors, Progesterone | 1 | 2015 | 356 | 0.020 |
Why?
| | Personnel Selection | 1 | 2015 | 93 | 0.020 |
Why?
| | Insurance, Health | 1 | 2016 | 303 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1998 | 2032 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2147 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2015 | 783 | 0.020 |
Why?
| | Disease Progression | 2 | 2017 | 2852 | 0.020 |
Why?
| | Drainage | 1 | 2014 | 185 | 0.020 |
Why?
| | Child Development | 1 | 1998 | 484 | 0.020 |
Why?
| | Educational Measurement | 1 | 2016 | 326 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 457 | 0.020 |
Why?
| | Patient Readmission | 1 | 2018 | 759 | 0.020 |
Why?
| | Insulin | 1 | 2003 | 2507 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2014 | 539 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2019 | 1167 | 0.020 |
Why?
| | Alcoholism | 1 | 1999 | 817 | 0.020 |
Why?
| | Multiple Sclerosis | 1 | 1998 | 484 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 1998 | 676 | 0.020 |
Why?
| | Perception | 1 | 2015 | 377 | 0.020 |
Why?
| | Text Messaging | 1 | 2014 | 182 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4275 | 0.020 |
Why?
| | Escherichia coli | 1 | 2016 | 855 | 0.020 |
Why?
| | Specialty Boards | 1 | 2011 | 42 | 0.020 |
Why?
| | Phenotype | 1 | 1999 | 3164 | 0.020 |
Why?
| | Faculty | 1 | 2011 | 149 | 0.020 |
Why?
| | Registries | 1 | 2019 | 2385 | 0.020 |
Why?
| | Medicaid | 1 | 2014 | 462 | 0.020 |
Why?
| | Interferon beta-1a | 2 | 2000 | 14 | 0.020 |
Why?
| | New York City | 1 | 2009 | 89 | 0.020 |
Why?
| | Physicians | 1 | 2018 | 940 | 0.020 |
Why?
| | Urban Health Services | 1 | 2009 | 71 | 0.020 |
Why?
| | Gravidity | 1 | 2008 | 7 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 2000 | 141 | 0.020 |
Why?
| | Students | 1 | 2014 | 663 | 0.020 |
Why?
| | Southwestern United States | 1 | 2008 | 95 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 84 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 983 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3550 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 3192 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2011 | 901 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 200 | 0.020 |
Why?
| | Puberty | 1 | 2008 | 140 | 0.020 |
Why?
| | Aging | 1 | 1998 | 1966 | 0.020 |
Why?
| | Urine | 1 | 2007 | 62 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2430 | 0.020 |
Why?
| | Medical Indigency | 1 | 2006 | 11 | 0.020 |
Why?
| | Social Perception | 1 | 2008 | 107 | 0.020 |
Why?
| | Urinalysis | 1 | 2007 | 80 | 0.020 |
Why?
| | Research Support as Topic | 1 | 2007 | 80 | 0.020 |
Why?
| | Forecasting | 1 | 2008 | 391 | 0.020 |
Why?
| | Education | 1 | 2007 | 104 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2007 | 143 | 0.020 |
Why?
| | Social Environment | 1 | 2008 | 254 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 280 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11799 | 0.010 |
Why?
| | Hospitalization | 1 | 2016 | 2434 | 0.010 |
Why?
| | Triglycerides | 1 | 2008 | 521 | 0.010 |
Why?
| | Universities | 1 | 2007 | 452 | 0.010 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2004 | 34 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2738 | 0.010 |
Why?
| | Attention | 2 | 1999 | 458 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 372 | 0.010 |
Why?
| | Self Concept | 1 | 2005 | 253 | 0.010 |
Why?
| | Sex Characteristics | 2 | 1999 | 791 | 0.010 |
Why?
| | Research | 1 | 2005 | 431 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2005 | 1325 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1997 | 781 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1769 | 0.010 |
Why?
| | Electromagnetic Fields | 1 | 1999 | 38 | 0.010 |
Why?
| | Schizophrenic Psychology | 1 | 1999 | 97 | 0.010 |
Why?
| | Wechsler Scales | 1 | 1998 | 59 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 2330 | 0.010 |
Why?
| | Sound Localization | 1 | 1998 | 61 | 0.010 |
Why?
| | Gadolinium | 1 | 1998 | 84 | 0.010 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 1999 | 285 | 0.010 |
Why?
| | Cognition | 1 | 2005 | 1269 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1999 | 479 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 1995 | 76 | 0.010 |
Why?
| | Confidence Intervals | 1 | 1996 | 333 | 0.010 |
Why?
| | Verbal Behavior | 1 | 1995 | 43 | 0.010 |
Why?
| | Space Perception | 1 | 1995 | 83 | 0.010 |
Why?
| | Cognition Disorders | 1 | 1999 | 538 | 0.010 |
Why?
| | Recurrence | 1 | 1998 | 1135 | 0.010 |
Why?
| | Software | 1 | 1999 | 692 | 0.010 |
Why?
|
|
Sheeder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|